At the end of this conference delegates shall learn:
- The latests advances in diagnosis and treatment of Pediatric Autoimmune Neuropsychiatric Disorder Associated with the Streptococcus (PANDAS) and Pediatric Autoimmune Neuropsychiatric Syndrome (PANS).
- Inspect evidence for and against the diagnostic presentation of PANDAS and PANS.
- Clarify the neuropsychiatric symptoms associated with PANS and PANDAS.
- Select the appropriate laboratory indicators predictive of PANDAS/PANS.
- Discuss the etiology and the most recent supporting scientific evidence for these diagnoses.
- Describe the various treatment protocols and their individual fit for clinical cases.
Presentations of the latest scientific advances in the diagnosis and treament of PANS/PANDAS shall include topics touching immunology, rheumatology, neurology, child psychiatry, psychology and more.
- “PANDAS Psychiatric Management” – Dr. M. Chiappedi, Prof. U. Balottin, Neuropsichiatria Infantile, IRCCS “C.Mondino”, Pavia
- “Anti-neuronal Autoantibodies in PANDAS/PANS and Beyond” – Madeleine W. Cunningham, PhD Chief Scientific Officer, Moleculera Labs, Research Professor, University of Oklahoma Health Sciences Center, USA
- “In the Trenches — Clinical Case Study Summary” – Elizabeth Latimer, MD Child Neurology Georgetown University, USA
- “Recognition and Diagnosis of Pediatric Acute Onset Neuropsychiatric Syndrome” – James F. Leckman, MD, PhD, Prof. Child Psychiatry, Psychology and Pediatrics, Yale School of Medicine
- “PANDAS: Clinica, Therapy & Follow-Up su la più Grande Casistica di Bambini e Adolescenti Italiani” – Dr. A. Meini, Brescia & Prof. F. Falcini, MD Universita’ degli Studi, Firenze
- “PANDAS 100 Cases – Phenotype Review” – Diana Pohlman, Founder & Director, Pandas Network, Palo Alto, USA
- “PANDAS IVIG and other Therapies” – Dr. S, Savasta, S. Matteo, Pavia
- “When the Symptomatology has a Different Etiological Agent” – Dott, Prof. Alberto Spalice, MD Responsible UOC, Pediatric Neurology, University Sapienza, Roma
- “From Research Subgroup to Clinical Syndrome: Modifying the PANDAS Criteria to Describe PANS” – S. Swedo, MD Chief Pediatric Neuroscience, National Institute of Health NIH, USA
- “PANDAS Treatment – Rebalancing T helper Cell Polarization” – Christopher Turnpaugh, Turnpaugh Wellness Center, USA and Samuel F. Yanuck, Center for Life and Health, USA
- “Diagnostic Differentiation between PANDAS and Obsessive Compulsive Disorder” – Aristo Vojdani, PhD MSc MT Chief Scientific Officer, ImmunoScience Labs, Professor Neuroimmunology, Carrick Institute for Graduate Studies, USA
Pediatricians, child psychologists, educational psychologists, social workers, specialists in childhood psychiatry, immunology, integrative medicine, infectious disease, neurobiology, neurology, rheumatology and functional medicine.
Continuing Medical Education (CME)
CME will be available within two weeks of the conference. The American Medical Association AMA has agreed to grant CME for European CME upon application.
- Dott, Prof. Alberto Spalice, MD Responsible UOC, Pediatric Neurology, University Sapienza, Roma
- Prof. Fernanda Falcini, Pediatric Rheumatology, Universita´degli Studi di Firenze
- Dott. Salvatore Savasta, Fondazione IRCCS Policlinico San Matteo, Pavia
Digital Poster Contribution
The content of PANDAS digital posters are presentations of your latest scientific advances in the diagnosis and treament of PANDAS, a unique approach, a study, the preview of an upcoming journal paper or a report (for example, describing a case of research integration and implementation or an innovative interdisciplinary approach).
We want you to showcase your achievements in research integration and clinical cases– all of them! Digital posters are short and punchy, allowing you to review a lot of contributions quickly. But they also provide references and links to help delegates reference topics of particular interest.
We are looking forward to an international cross discipline platform that reaches across borders and bridges both clinical and scientific approach.